• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

siRNA 阻断哺乳动物雷帕霉素靶蛋白 (mTOR) 可减轻瓜氨酸诱导的tau 病小鼠的病理损伤。

siRNA Blocking of Mammalian Target of Rapamycin (mTOR) Attenuates Pathology in Annonacin-Induced Tauopathy in Mice.

机构信息

Medical Experimental Research Center (MERC), Faculty of Medicine, Mansoura University, Elgomhourya street, Mansoura, 36551, Egypt.

Toxicology Department, Faculty of Medicine, Mansoura University, Mansoura, Egypt.

出版信息

Neurotox Res. 2019 May;35(4):987-992. doi: 10.1007/s12640-018-9974-3. Epub 2018 Oct 25.

DOI:10.1007/s12640-018-9974-3
PMID:30362086
Abstract

Tauopathy is a pathological hallmark of many neurodegenerative diseases. It is characterized by abnormal aggregates of pathological phosphotau and somatodendritic redistribution. One suggested strategy for treating tauopathy is to stimulate autophagy, hence, getting rid of these pathological protein aggregates. One key controller of autophagy is mTOR. Since stimulation of mTOR leads to inhibition of autophagy, inhibitors of mTOR will cause stimulation of autophagy process. In this report, tauopathy was induced in mice using annonacin. Blocking of mTOR was achieved through stereotaxic injection of siRNA against mTOR. The behavioral and immunohistochemical evaluation revealed the development of tauopathy model as proven by deterioration of behavioral performance in open field test and significant tau aggregates in annonacin-treated mice. Blocking of mTOR revealed significant clearance of tau aggregates in the injected side; however, tau expression was not affected by mTOR blockage.

摘要

tau 病是许多神经退行性疾病的病理特征。其特征在于病理性磷酸化 tau 的异常聚集和树突状分布。一种治疗 tau 病的建议策略是刺激自噬,从而清除这些病理性蛋白聚集体。自噬的一个关键控制器是 mTOR。由于 mTOR 的刺激会导致自噬的抑制,因此 mTOR 的抑制剂会引起自噬过程的刺激。在本报告中,使用 annonacin 在小鼠中诱导 tau 病。通过立体定向注射 mTOR 的 siRNA 来实现 mTOR 的阻断。行为学和免疫组织化学评估显示 tau 病模型的发展,正如在开放场测试中行为表现恶化以及 annonacin 处理的小鼠中存在明显的 tau 聚集所证明的那样。mTOR 的阻断显示出 tau 聚集体在注射侧的显著清除;然而,mTOR 阻断对 tau 表达没有影响。

相似文献

1
siRNA Blocking of Mammalian Target of Rapamycin (mTOR) Attenuates Pathology in Annonacin-Induced Tauopathy in Mice.siRNA 阻断哺乳动物雷帕霉素靶蛋白 (mTOR) 可减轻瓜氨酸诱导的tau 病小鼠的病理损伤。
Neurotox Res. 2019 May;35(4):987-992. doi: 10.1007/s12640-018-9974-3. Epub 2018 Oct 25.
2
Dual mTORC1/mTORC2 blocker as a possible therapy for tauopathy in cellular model.双重 mTORC1/mTORC2 抑制剂作为细胞模型中 tau 病的一种潜在治疗方法。
Metab Brain Dis. 2018 Apr;33(2):583-587. doi: 10.1007/s11011-017-0137-7. Epub 2017 Oct 27.
3
Rapamycin ester analog CCI-779/Temsirolimus alleviates tau pathology and improves motor deficit in mutant tau transgenic mice.雷帕霉素酯类似物CCI-779/替西罗莫司可减轻突变型tau转基因小鼠的tau病理并改善运动功能障碍。
J Alzheimers Dis. 2015;44(4):1145-56. doi: 10.3233/JAD-142097.
4
Prolonged tau clearance and stress vulnerability rescue by pharmacological activation of autophagy in tauopathy neurons.通过自噬的药理学激活来清除 tau 并挽救 tau 病神经元的应激易损性。
Nat Commun. 2020 Jun 26;11(1):3258. doi: 10.1038/s41467-020-16984-1.
5
Annonacin, a natural lipophilic mitochondrial complex I inhibitor, increases phosphorylation of tau in the brain of FTDP-17 transgenic mice.安纳咖宁,一种天然亲脂性线粒体复合物 I 抑制剂,可增加 FTDP-17 转基因小鼠大脑中的 tau 磷酸化。
Exp Neurol. 2014 Mar;253:113-25. doi: 10.1016/j.expneurol.2013.12.017. Epub 2014 Jan 3.
6
mTor mediates tau localization and secretion: Implication for Alzheimer's disease.mTor介导tau蛋白的定位与分泌:对阿尔茨海默病的意义。
Biochim Biophys Acta. 2015 Jul;1853(7):1646-57. doi: 10.1016/j.bbamcr.2015.03.003. Epub 2015 Mar 17.
7
Temsirolimus attenuates tauopathy in vitro and in vivo by targeting tau hyperphosphorylation and autophagic clearance.替西罗莫司通过靶向tau蛋白过度磷酸化和自噬清除在体外和体内减轻tau蛋白病。
Neuropharmacology. 2014 Oct;85:121-30. doi: 10.1016/j.neuropharm.2014.05.032. Epub 2014 May 29.
8
Infantile tauopathies: Hemimegalencephaly; tuberous sclerosis complex; focal cortical dysplasia 2; ganglioglioma.婴儿期tau蛋白病:半侧巨脑症;结节性硬化症复合体;局灶性皮质发育不良2型;神经节胶质瘤。
Brain Dev. 2015 Jun;37(6):553-62. doi: 10.1016/j.braindev.2014.08.010. Epub 2014 Oct 19.
9
Pharmacological Inhibition of O-GlcNAcase Enhances Autophagy in Brain through an mTOR-Independent Pathway.O-连接的 N-乙酰氨基葡萄糖苷酶的药理学抑制通过一种 mTOR 非依赖性途径增强脑内自噬。
ACS Chem Neurosci. 2018 Jun 20;9(6):1366-1379. doi: 10.1021/acschemneuro.8b00015. Epub 2018 Mar 5.
10
Analysis of ribosomal protein S6 baseline phosphorylation and effect of tau pathology in the murine brain and human hippocampus.核糖体蛋白S6基线磷酸化分析以及tau病理改变对小鼠脑和人类海马体的影响。
Brain Res. 2017 Mar 15;1659:121-135. doi: 10.1016/j.brainres.2017.01.016. Epub 2017 Jan 22.

引用本文的文献

1
Impairment of Nrf2 signaling in the hippocampus of P301S tauopathy mice model aligns with the cognitive impairment and the associated neuroinflammation.P301S 型 tau 蛋白病小鼠模型海马体中 Nrf2 信号通路的损伤与认知障碍及相关神经炎症一致。
J Inflamm (Lond). 2024 Aug 6;21(1):29. doi: 10.1186/s12950-024-00396-9.
2
Progressive Supranuclear Palsy Syndrome: An Overview.进行性核上性麻痹综合征概述
IBRO Neurosci Rep. 2024 May 6;16:598-608. doi: 10.1016/j.ibneur.2024.04.008. eCollection 2024 Jun.
3
Tauopathies: new perspectives and challenges.

本文引用的文献

1
Dual mTORC1/mTORC2 blocker as a possible therapy for tauopathy in cellular model.双重 mTORC1/mTORC2 抑制剂作为细胞模型中 tau 病的一种潜在治疗方法。
Metab Brain Dis. 2018 Apr;33(2):583-587. doi: 10.1007/s11011-017-0137-7. Epub 2017 Oct 27.
2
Chronic consumption of Annona muricata juice triggers and aggravates cerebral tau phosphorylation in wild-type and MAPT transgenic mice.长期饮用刺果番荔枝汁会引发并加剧野生型和微管相关蛋白tau(MAPT)转基因小鼠的大脑tau蛋白磷酸化。
J Neurochem. 2016 Nov;139(4):624-639. doi: 10.1111/jnc.13835. Epub 2016 Sep 16.
3
The mTOR Inhibitor Rapamycin Mitigates Perforant Pathway Neurodegeneration and Synapse Loss in a Mouse Model of Early-Stage Alzheimer-Type Tauopathy.
tau 病:新视角与新挑战。
Mol Neurodegener. 2022 Apr 7;17(1):28. doi: 10.1186/s13024-022-00533-z.
4
Parkinson's Disease and Impairment in Mitochondrial Metabolism: A Pathognomic Signature.帕金森病与线粒体代谢障碍:一种病征特征。
Adv Exp Med Biol. 2021;1286:65-76. doi: 10.1007/978-3-030-55035-6_4.
mTOR抑制剂雷帕霉素可减轻早期阿尔茨海默病型tau蛋白病小鼠模型中穿通通路的神经退行性变和突触丧失。
PLoS One. 2015 Nov 5;10(11):e0142340. doi: 10.1371/journal.pone.0142340. eCollection 2015.
4
Dual mTORC1/C2 inhibitors: gerosuppressors with potential anti-aging effect.双mTORC1/C2抑制剂:具有潜在抗衰老作用的衰老抑制剂
Oncotarget. 2015 Sep 15;6(27):23052-4. doi: 10.18632/oncotarget.5563.
5
Tau silencing by siRNA in the P301S mouse model of tauopathy.在tau蛋白病的P301S小鼠模型中,通过小干扰RNA使tau蛋白沉默。
Curr Gene Ther. 2014;14(5):343-51. doi: 10.2174/156652321405140926160602.
6
Piericidin A aggravates Tau pathology in P301S transgenic mice.粉蝶霉素A加重P301S转基因小鼠的 Tau 病理变化。
PLoS One. 2014 Dec 1;9(12):e113557. doi: 10.1371/journal.pone.0113557. eCollection 2014.
7
Rapamycin improves peripheral nerve myelination while it fails to benefit neuromuscular performance in neuropathic mice.雷帕霉素可改善周围神经髓鞘形成,但对神经病变小鼠的神经肌肉功能无益处。
Neurobiol Dis. 2014 Oct;70:224-36. doi: 10.1016/j.nbd.2014.06.023. Epub 2014 Jul 9.
8
Genetic reduction of mammalian target of rapamycin ameliorates Alzheimer's disease-like cognitive and pathological deficits by restoring hippocampal gene expression signature.雷帕霉素靶蛋白的遗传减少通过恢复海马基因表达特征改善阿尔茨海默病样认知和病理缺陷。
J Neurosci. 2014 Jun 4;34(23):7988-98. doi: 10.1523/JNEUROSCI.0777-14.2014.
9
Temsirolimus attenuates tauopathy in vitro and in vivo by targeting tau hyperphosphorylation and autophagic clearance.替西罗莫司通过靶向tau蛋白过度磷酸化和自噬清除在体外和体内减轻tau蛋白病。
Neuropharmacology. 2014 Oct;85:121-30. doi: 10.1016/j.neuropharm.2014.05.032. Epub 2014 May 29.
10
Annonacin, a natural lipophilic mitochondrial complex I inhibitor, increases phosphorylation of tau in the brain of FTDP-17 transgenic mice.安纳咖宁,一种天然亲脂性线粒体复合物 I 抑制剂,可增加 FTDP-17 转基因小鼠大脑中的 tau 磷酸化。
Exp Neurol. 2014 Mar;253:113-25. doi: 10.1016/j.expneurol.2013.12.017. Epub 2014 Jan 3.